| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |